Tempest Therapeutics, Inc.
What this means
- Exchange listing at riskOn Nov 6, 2026 the company disclosed a notice from its exchange (Item 3.01). Exchanges usually give a period to regain compliance before delisting.
- Several leadership changes7 reports of director or officer changes (Item 5.02) in the last 180 days.
- Change in controlOn Feb 6, 2026 the company reported a change in control (Item 5.01).
- Net loss in 2025Net loss of $26.3M for the year (2024: −$41.8M).
- Private capital raiseOn Oct 14, 2026 the company filed Form D: $7.5M offered · $7.5M sold · Biotechnology. A Form D is a notice of an exempt offering, not an SEC approval; the figures are the issuer’s own.
What to do next
- How to check a US company before you sign a contractguide
- How to read an 8-K: what customers and creditors should checkguide
Guides from the Companies Daily newsroom, picked for what the register shows.
Financials from XBRL
| Calendar-year frame | 2025 | 2024 |
|---|---|---|
| Net income (loss) | −$26.3M | −$41.8M |
| Total assets | $16.9M | $41.5M |
| Total liabilities | $10.3M | $22.4M |
| Stockholders’ equity | $6.7M | $19.1M |
| Cash and equivalents | $7.7M | $30.3M |
From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.
- Name as filed
- Tempest Therapeutics, Inc.
Formerly: Millendo Therapeutics, Inc. - CIK
- 0001544227
- Tickers
- TPST
- Kind of filer
- SEC-reporting company
Non-accelerated filer; Smaller reporting company - Legal form
- Corporation
- Status
- Filing with the SEC
- State of incorporation
- Delaware
- Business address
- Brisbane, California
- Industry (SIC)
- 2834 · Pharmaceutical preparations
Industry: D · Manufacturing → - Fiscal year ends
- December 31
- Last annual report
- 10-K for the period ended Dec 31, 2025
- Last quarterly report
- 10-Q for the quarter ended Sep 30, 2026
- Latest exempt offering
- $7.5M offered · $7.5M sold
Revenue range stated: Decline to Disclose - Bankruptcy reported
- Not in our data
- Last edition event
- Nov 13, 2026
Filing history
Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.
- Form 10-Q · filed Nov 13, 2026 · filing · edition of Nov 13, 2026
- Form 8-K · items 2.02, 9.01 · filed Nov 13, 2026 · filing · edition of Nov 13, 2026
- Form 8-K · items 3.01 · filed Nov 6, 2026 · filing
- Form 8-K · items 5.02 · filed Oct 30, 2026 · filing
- Form 8-K · items 5.02, 7.01, 9.01 · filed Oct 19, 2026 · filing
- Form D · items 06B · filed Oct 14, 2026 · filing
- Form 8-K · items 1.01, 5.02, 7.01, 9.01 · filed Sep 28, 2026 · filing
- Form 8-K · items 5.02 · filed Aug 24, 2026 · filing
- Form S-1 · filed Aug 21, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 13, 2026 · filing
- Form 10-Q · filed Aug 13, 2026 · filing
- Form D · items 06b · filed Jun 23, 2026 · filing
- Form 8-K · items 5.02, 7.01, 9.01 · filed Jun 4, 2026 · filing
- Form 8-K · items 5.02 · filed May 29, 2026 · filing
- Form 8-K · items 5.02 · filed May 22, 2026 · filing
- Form 8-K · items 3.01 · filed May 22, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed May 14, 2026 · filing
- Form 10-Q · filed May 14, 2026 · filing
- Form D · items 06b · filed Apr 3, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 30, 2026 · filing
- Form 10-K · filed Mar 30, 2026 · filing
- Form SCHEDULE 13D · filed Feb 10, 2026 · filing
- Form 8-K · items 1.01, 2.01, 3.02, 5.01, 5.02, 9.01 · filed Feb 6, 2026 · filing
- Form 8-K · items 1.01, 2.01, 3.02, 5.01, 5.02, 9.01 · filed Feb 6, 2026 · filing
- Form 8-K · items 1.01, 2.01, 3.02, 5.01, 5.02, 9.01 · filed Feb 6, 2026 · filing
- Form 8-K · items 3.03, 5.02, 5.07 · filed Jan 28, 2026 · filing
- Form 8-K · items 3.01 · filed Jan 9, 2026 · filing
- Form S-1 · filed Dec 9, 2025 · filing
- Form 8-K · items 1.01, 3.02, 5.02, 8.01, 9.01 · filed Nov 19, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 5, 2025 · filing
- Form 10-Q · filed Nov 5, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 11, 2025 · filing
- Form 10-Q · filed Aug 11, 2025 · filing
- Form 8-K · items 5.02 · filed Jun 6, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed May 13, 2025 · filing
- Form 10-Q · filed May 13, 2025 · filing
- Form 8-K · items 2.05 · filed Apr 18, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 27, 2025 · filing
- Form 10-K · filed Mar 27, 2025 · filing
- Form 8-K · items 3.01 · filed Dec 31, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 12, 2024 · filing
- Form 10-Q · filed Nov 12, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 8, 2024 · filing
- Form 10-Q · filed Aug 8, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed May 9, 2024 · filing
- Form 10-Q · filed May 9, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 19, 2024 · filing
- Form 10-K · filed Mar 19, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 8, 2023 · filing
- Form 10-Q · filed Nov 8, 2023 · filing
- Form 8-K · items 3.01 · filed Sep 8, 2023 · filing
- Form 8-K · items 5.02 · filed Sep 7, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 10, 2023 · filing
- Form 10-Q · filed Aug 10, 2023 · filing
- Form 8-K · items 5.02, 5.07 · filed Jun 16, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed May 10, 2023 · filing
- Form 10-Q · filed May 10, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 22, 2023 · filing
- Form 10-K · filed Mar 22, 2023 · filing